Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A pilot study that seeks to develop a set of typologies of users of mobile sleep tracking technologies, and optimal sleep health educational strategies among users of mobile wearable technologies that track sleep.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Receive sleep health messages + GAD | Active Comparator | Procedures will be delivered to users of the GAD, individuals who have opted in via their smartphone application, to receive messages about various areas of health. |
|
| Sleep message No GAD | Active Comparator | For two weeks participants agree to receive sleep health messages and wear the GAD |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Specialized sleep-related message interventions | Behavioral | Over the course of 2 weeks' participants will receive specialized sleep-related message interventions to encourage sleep awareness via the smartphone application. |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep time measured by wearable mobile sleep tracking technology | Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients | 15 Days |
| Time in deep sleep measured by wearable mobile sleep tracking technology | Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients | 15 Days |
| Dysfunctional Beliefs about Sleep (DBAS) scale | 24-item DBAS scale with five subscales corresponding to: (1) consequences of insomnia (2) control and predictability of sleep (3) sleep requirement expectations (5) sleep-promoting practices | 1 Day |
| Measure of motivation to change using the Change Assessment Scale (CAS) | 8 scale measure divided into 4 separate scales: Scale 1: "Pre-Contemplation" Scale 2: "Contemplation" Scale 3 "Action" Scale 4 "Maintenance" | 15 Days |
Not provided
Not provided
Inclusion Criteria:
For Aim 3 MOST message testing, the inclusion criteria include the following:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Girardin Jean-Louis, MD | NYU Langone Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York University School of Medicine | New York | New York | 10016 | United States |
All of the individual participant data collected during the trial, after deidentification.
Immediately following publication. No end date
Requests should be directed to Rebecca.robbins@nyulangone.org. To gain access, data requestors will need to sign a data access agreement
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| GAD | Behavioral | Survey responses will be merged with objective GAD data (sleep time, time in deep sleep, physical activity) which will assist in developing message design formats for message testing. |
|